US Patent 10953089 Coronavirus vaccine formulations
Patent 10953089 was granted and assigned to Novavax on March, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10953089 Coronavirus vaccine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
